Targeting 90–90–90 – don't leave children and adolescents behind
نویسندگان
چکیده
925. 45. Peacock-Villada E, Richardson BA, John-Stewart GC. Post-HAART outcomes in pediatric populations: comparison of resource-limited and developed countries. Pediatrics. 2011;127:e423 41. 46. Sutcliffe CG, van Dijk JH, Bolton C, Persaud D, Moss WJ. Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. Lancet Infect Dis. 2008;8:477 89. 47. Leroy V, Malateste K, Rabie H, Lumbiganon P, Ayaya S, Dicko F, et al. Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration. J Acquir Immune Defic Syndr. 2013;62:208 19. 48. McNairy ML, Lamb MR, Carter RJ, Fayorsey R, Tene G, Mutabazi V, et al. Retention of HIV-infected children on antiretroviral treatment in HIV care and treatment programs in Kenya, Mozambique, Rwanda, and Tanzania. J Acquir Immune Defic Syndr. 2013;62:e70 81. 49. Sigaloff KC, Calis JC, Geelen SP, van Vugt M, de Wit TF. HIV-1-resistanceassociated mutations after failure of first-line antiretroviral treatment among children in resource-poor regions: a systematic review. Lancet Infect Dis. 2011;11:769 79. 50. Barth RE, van der Loeff MF, Schuurman R, Hoepelman AI, Wensing AM. Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review. Lancet Infect Dis. 2010;10: 155 66. 51. Meyers T, Sawry S, Wong JY, Moultrie H, Pinillos F, Fairlie L, et al. Virologic failure among children taking lopinavir/ritonavir-containing first-line antiretroviral therapy in South Africa. Pediatr Infect Dis J. 2015;34:175 9. 52. Nachega JB, Hislop M, Nguyen H, Dowdy DW, Chaisson RE, Regensberg L, et al. Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa. J Acquir Immune Defic Syndr. 2009;51:65 71. 53. Cluver L, Hodes R, Sherr L, Orkin MF, Meinck F, Lim ah Ken P, et al. Social protection: potential for improving HIV outcomes among adolescents. J Int AIDS Soc. 2015;18(Suppl 6):20299, doi: http://dx.doi.org/10.7448/IAS.18.7.20260 54. Lee S, Hazra R. Achieving 90-90-90 in pediatric HIV: adolescence as the touchstone for transition success. J Int AIDS Soc. 2015;18(Suppl 6):20257, doi: http://dx.doi.org/10.7448/IAS.18.7.20257 55. World Health Organization (2014). Fact sheet on adolescent health. [cited 2015 Sep 4]. Available from: http://www.unaids.org/en/media/unaids/ contentassets/documents/factsheet/2012/20120417_FS_adolescentsyoungpeoplehiv_en.pdf 56. World Health Organization (2014). Health for the world’s adolescents: a second chance in the second decade. [cited 2015 Sep 30]. Available from: http://www.who.int/maternal_child_adolescent/topics/adolescence/seconddecade/en/ 57. Fish R, Judd A, Jungmann E, O’Leary C, Foster C. Mortality in perinatally HIV-infected young people in England following transition to adult care: an HIV Young Persons Network (HYPNet) audit. HIV Med. 2014;15:239 44. Davies M-A and Pinto J. Journal of the International AIDS Society 2015, 18(Suppl 6):20745 http://www.jiasociety.org/index.php/jias/article/view/20745 | http://dx.doi.org/10.7448/IAS.18.7.20745
منابع مشابه
Getting to 90–90–90 targets for children and adolescents HIV in low and concentrated epidemics: bottlenecks, opportunities, and solutions
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License, where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially. Combating HIV has seen some of the greatest achievement in the history of global health, for example, reaching 15 m...
متن کامل90-90-90--Charting a steady course to end the paediatric HIV epidemic.
INTRODUCTION The new "90-90-90" UNAIDS agenda proposes that 90% of all people living with HIV will know their HIV status, 90% of all people with diagnosed HIV infection will receive sustained antiretroviral therapy and 90% of all people receiving antiretroviral therapy will have viral suppression by 2020. By focusing on children, the global community is in the unique position of realizing an en...
متن کاملWelfare and Family Stability: Do Benefits Affect When Children Leave the Nest?
The welfare system has long been criticized for its incentives against marriage. This paper examines one way in which welfare actually may keep families together: the fact that benefits increase with family size may encourage teenagers to stay in welfare-recipient households. Welfare benefit incentives affecting coresidence are twofold: (i) a parent loses benefits if a child leaves the househol...
متن کاملOptimizing drugs to reach treatment targets for children and adolescents living with HIV
INTRODUCTION As the global community makes progress towards the 90-90-90 targets by 2020, a key challenge is ensuring that antiretroviral drugs for children and adolescents are suitable to the context of resource-limited settings. Drug optimization aims to support the expanded use of more simplified, less toxic drug regimens with high barriers to drug resistance that require minimal clinical mo...
متن کاملAchieving 90-90-90 in paediatric HIV: adolescence as the touchstone for transition success.
INTRODUCTION The number of children less than 15 years estimated to be living with HIV globally approximated 3.2 million in 2013. Young people aged 15 to 24 years living with HIV approximated 4 million. The survival of these children and adolescents into adulthood poses new and urgent challenges of transition from the paediatric to adolescent to adult healthcare settings due to emerging develop...
متن کامل